Kusava Sciences Tests Alzheimer's Drug Semufilm
Texas-based Kusava Sciences is researching Semufilm, an experimental drug designed to treat Alzheimer's disease. The company's research, involving collaborator Hao Yan Wang from the City University of New York, focuses on reversing the misfolding of protein filaments. This shift in focus follows the company's previous attempts to enter the opioid market.
Topics
Developing
- 863d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 863d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 863d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 863d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
WBUR Boston
“Kusava Sciences had been known earlier as pain therapeutics. They spent years trying to break into the opioid market, and then they switched their focus to semufilm, an experimental drug for Alzheimer's.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade